Skip to main content
SpringerLink
Log in

Quality of Life Issues

  • Chapter
  • First Online:
Dyspepsia in Clinical Practice

  • 605 Accesses

Abstract

Nowadays, the main method for assessing the efficiency of pharmacologic therapies are the randomized controlled trials (RCTs), which are regarded as an objective measure of the biologic response of the patients to a given treatment. However, beside quantifying therapeutic responses, there are many other subjective factors (emotional factors such as depression or anxiety, ability to perform daily activities at the workplace or at home, changes in eating/sleeping, social, familiar, and sexual habits), which are difficult to assess using quantitative methods. Both dyspepsia and quality of life (QoL) are ill-defined terms [1, 2]. Physicians traditionally prefer to use objective methods to diagnose and monitor treatment responses. However, many gastrointestinal diseases have a high symptom burden and enormous health-care costs but little objective evidence of the disease; this is especially true for the large group of functional disorders to which dyspepsia belongs [3, 4].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Fayer PM, Machin D, editors. Quality of life. Assessment, analysis and interpretation. Chichester: Wiley; 2000.

    Google Scholar 

  2. Bytzer P, Tally NJ. Dyspepsia. Ann Intern Med. 2001;134:815–22.

    PubMed  CAS  Google Scholar 

  3. Wiklund I. Patient-reported outcomes. In: Talley NJ, Locke III GR, Saito YA, editors. GI epidemiology. Oxford: Blackwell; 2006. p. 24–30.

    Google Scholar 

  4. Creed F, Levy RL, Bradley LA, et al. Psychosocial aspects of functional gastrointestinal disoders. In: Drossman DA, Corazziari E, Spiller RC, Thompson WG, editors. The functional gastrointestinal disorders, Rome III. McLean, VA: Degnon Associates; 2006. p. 313–4. 318–21, 346–7.

    Google Scholar 

  5. Locke III GR. GI questionnaires. In: Talley NJ, Locke III GR, Saito YA, editors. GI epidemiology. Oxford: Blackwell; 2006. p. 30–4.

    Google Scholar 

  6. Borenstein M, Hedges LV, Higgins JPT, Rothstein HR, editors. Introduction to meta-analysis. Chichester: Wiley; 2009.

    Google Scholar 

  7. Yacavone RF, Locke 3rd GR, Provenzale DT, Eisen GM. Quality of life measurement in gastroenterology: what is available? Am J Gastroenterol. 2001;96:285–97.

    Article  PubMed  CAS  Google Scholar 

  8. Dimenas E, Glise H, Hallerback B, Hernquist H, Svedlund J, Wiklund I. Well-being and gastrointestinal symptoms among patients referred to endoscopy owing to suspected duodenal ulcer. Scand J Gastroenterol. 1995;30:1046–52.

    Article  PubMed  CAS  Google Scholar 

  9. el-Omar EM, Banerjee S, Wirz A, McColl KE. The Glasgow Dyspepsia Severity Score: a tool for the global measurement of dyspepsia. Eur J Gastroenterol Hepatol. 1996;8:967–71.

    Article  PubMed  CAS  Google Scholar 

  10. Moayyedi P, Duffett S, Braunholtz D, et al. The Leeds Dyspepsia Questionnaire: a valid tool for measuring the presence and severity of dyspepsia. Aliment Pharmacol Ther. 1998;12:1257–62.

    Article  PubMed  CAS  Google Scholar 

  11. Wiklund I, Junghard O, Grace E, et al. Quality of Life in Reflux and Dyspepsia patients. Psychometric documentation of a new disease-specific questionnaire (QOLRAD). Eur J Surg Suppl. 1998; 583:41–9.

    Google Scholar 

  12. Enck P, Dubois D, Marquis P. Quality of life in patients with upper gastrointestinal symptoms: results from the Domestic/International Gastroenterology Surveillance Study (DIGEST). Scand J Gastroenterol Suppl. 1999;231:48–54.

    PubMed  CAS  Google Scholar 

  13. Chassany O, Marquis P, Scherrer B, et al. Validation of a specific quality of life questionnaire for functional digestive disorders. Gut. 1999;44:527–33.

    Article  PubMed  CAS  Google Scholar 

  14. Talley NJ, Haque M, Wyeth JW, et al. Development of a new dyspepsia impact scale: the Nepean Dyspepsia Index. Aliment Pharmacol Ther. 1999;13:225–35.

    Article  PubMed  CAS  Google Scholar 

  15. Bamfi F, Oliveri A, Arpinelli F, et al. Measuring quality of life in dyspeptic patients: development and validation of a new specific health status questionnaire: final report from the Italian QPD project involving 4000 patients. Am J Gastroenterol. 1999;94:730–8.

    PubMed  CAS  Google Scholar 

  16. Cook KF, Rabeneck L, Campbell CJ, Wray NP. Evaluation of a multidimensional measure of dyspepsia-related health for use in a randomized clinical trial. J Clin Epidemiol. 1999;52:381–92.

    Article  PubMed  CAS  Google Scholar 

  17. Leidy NK, Farup C, Rentz AM, Ganoczy D, Koch KL. Patient-based assessment in dyspepsia:development and validation of Dyspepsia Symptoms Severity Index (DSSI). Dig Dis Sci. 2000;45:1172–9.

    Article  PubMed  CAS  Google Scholar 

  18. Talley NJ, Verlinden M, Jones M. Quality of life in functional dyspepsia: responsiveness of the Nepean Dyspepsia Index and development of a new 10-item short form. Aliment Pharmacol Ther. 2001;15:207–16.

    Article  PubMed  CAS  Google Scholar 

  19. Rabeneck L, Cook KF, Wristers K, Souchek J, Menke T, Wray NP. SODA (severity of dyspepsia assessment): a new effective outcome measure for dyspepsia-related health. J Clin Epidemiol. 2001;54:755–65.

    Article  PubMed  CAS  Google Scholar 

  20. Tian XP, Li Y, Liang FR, et al. Translation and validation of the Nepean Dyspepsia Index for functional dyspepsia in China. World J Gastroenterol. 2009;15:3173–7.

    Article  PubMed  Google Scholar 

  21. Veldhuyzen van Zanten SJ, Chiba N, Amstrong D, et al. Validation of a 7-point Global Overall Symptom scale to measure the severity of dyspepsia symptoms in clinical trials. Aliment Pharmacol Ther. 2006;23:521–9.

    Article  PubMed  CAS  Google Scholar 

  22. Lee EH, Hahm KB, Lee HJ, et al. Development and validation of a functional dyspepsia-related quality of life (FD-QOL) scale in South Korea. J Gastroenterol Hepatol. 2006;21:268–74.

    Article  PubMed  Google Scholar 

  23. Mahadeva S, Wee HL, Goh KL, Thumboo L. The EQ-5D (Euroqol) is a valid generic instrument for measuring quality of life in patients with dyspepsia. BMC Gastroenterol. 2009;9:20.

    Article  PubMed  Google Scholar 

  24. Talley NJ, Ruff K, Jiang X, Jung HK. The Rome III Classification of dyspepsia: will it help research? Dig Dis Sci. 2008;26:203–9.

    Article  Google Scholar 

  25. Moayyedi P, Forman D, Braunholz D, et al. The proportion of upper gastrointestinal symptoms in the community associated with Helicobacter pylori, lifestyle factors, and nonsteroidal anti-inflammatory drugs. Leeds HELP Study Group. Am J Gastroenterol. 2000;95:1448–55.

    Article  PubMed  CAS  Google Scholar 

  26. Moayyedi P, Feltbower L, Brown J, et al. Effect of population screening and treatment for Helicobacter pylori on dyspepsia and quality of life in the community: a randomised controlled trial. Leeds HELP Study Group. Lancet. 2000;355:1665–9.

    Article  PubMed  CAS  Google Scholar 

  27. Piessevaux H, De Winter B, Louis E, et al. Dyspeptic symptoms in the general population: a factor and cluster analysis of symptom groupings. Neurogastroenterol Motil. 2009;21:378–88.

    Article  PubMed  CAS  Google Scholar 

  28. Meineche-Schmidt V, Talley NJ, Pap Á, et al. Impact of functional dyspepsia on quality of life and health care consumption after cessation of antisecretory treatment. A multicentre 3-month follow-up study. Scand J Gastroenterol. 1999;34:566–74.

    Article  PubMed  CAS  Google Scholar 

  29. Buzás GM. Quality of life in patients with functional dyspepsia: short- and long- term effect of Helicobacter pylori eradication with pantoprazole, amoxicillin, and clarithromycin or cisparide therapy: a prospective, parallel-group study. Curr Ther Res. 2006;67:305–20.

    Article  Google Scholar 

  30. Haag S, Senf W, Häuser W, et al. Impairement of health-related quality of life in functional dyspepsia and chronic liver disease: the influence of depression and anxiety. Aliment Pharmacol Ther. 2008;27:561–71.

    Article  PubMed  CAS  Google Scholar 

  31. Talley NJ, Locke III GR, Lahr BD, et al. Functional dyspepsia, delayed gastric empyting and impaired quality of life. Gut. 2006;55:933–9.

    Article  PubMed  CAS  Google Scholar 

  32. Holtmann G, Adam B, Haag S, Collet W, Grünewald E, Windeck T. Efficacy of artichoke leaf extract in the treatment of patients with functional dyspepsia: a six-week placebo-controlled, double-blind, multicentre trial. Aliment Pharmacol Ther. 2003;18:1099–105.

    Article  PubMed  CAS  Google Scholar 

  33. Veldhuyzen van Zanten SJ, Chiba N, Armstrong D, et al. A randomized trial comparing omeprazole, ranitidine, cisapride, or placebo in Helicobacter pylori negative, primary care patients with dyspepsia: the CADET-HN Study. Am J Gastroenterol. 2005;100:1477–88.

    Article  PubMed  CAS  Google Scholar 

  34. Holtmann G, Talley NJ, Liebregtd T, Adam B, Parow C. A placebo-controlled trial of itopride in functional dyspepsia. N Engl J Med. 2006;354:832–40.

    Article  PubMed  CAS  Google Scholar 

  35. van Zanten SV, Armstrong D, Chiba N, et al. Esomeprazole 40 mg once a day in patients with functional dyspepsia: the randomized placebo-controlled “ENTER” trial. Am J Gastroenterol. 2006;101:2096–106.

    Article  PubMed  Google Scholar 

  36. Raedsch R, Hanisch J, Bock P, Sibaev A, Vinson B, Gundermann KJ. Assessment of the efficacy and safety of the phytopharmacon STW 5 versus metoclopramide in functional dyspepsia: a retrolective cohort study. Z Gastroenterol. 2007;45:1041–8.

    Article  PubMed  CAS  Google Scholar 

  37. Talley NJ, Tack J, Ptak K, Gupta R, Giguère M. Itopride in functional dyspepsia: results of two phase III multicentre, randomised, double-blind, placebo-controlled trials. Gut. 2008;57:740–6.

    Article  PubMed  CAS  Google Scholar 

  38. Vakil N, Kianifard F, Bottoli I. Exploratory study of tegaserod for dyspepsia in women receving ppis for heartburn. Arch Drug Inf. 2008;1:79–88.

    Article  PubMed  CAS  Google Scholar 

  39. van Kerkhoven LA, Laheij RJ, Aparicio N, et al. Effect of the antidepressant venlafaxine in functional dyspepsia: a randomized, double-blind, placebo-controlled trial. Clin Gastroenterol Hepatol. 2008;6:746–52.

    Article  PubMed  Google Scholar 

  40. Miwa H, Nagahara A, Tominaga K, et al. Efficacy of the 5-HT1A agonist tandospirone citrate im improving symptoms of patients with functional dyspepsia: a randomized controlled trial. Am J Gastroenterol. 2009;104:2779–87.

    Article  PubMed  CAS  Google Scholar 

  41. Park YC, Kang W, Choi SM, Son CG. Evaluation of manual acupuncture at classical and nondefined points for treatment of functional dyspepsia: a randomized-controlled trial. J Altern Complement Med. 2009;15:879–84.

    Article  PubMed  Google Scholar 

  42. Braden B, Caspary W, Börner N, Vinson B, Schneider AR. Clinical effects of STW 5 (Iberogast) are not based on acceleration of gastric emptying in patients with functional dyspepsia and gastroparesis. Neurogastroenterol Motil. 2009;21:632–8.

    Article  PubMed  CAS  Google Scholar 

  43. Suzuki H, Inadomi JM, Hibi T. Japanese herbal medicine in functional gastrointestinal disorders. Neurogastroenterol Motil. 2009;21:688–96.

    Article  PubMed  CAS  Google Scholar 

  44. Malfertheiner P, Mégraud F, O’Morain C, et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut. 2007;56:772–81.

    Article  PubMed  CAS  Google Scholar 

  45. Moayyedi P, Soo S, Deeks J, et al. Eradication of Helicobacter pylori for non-ulcer dyspepsia. Cochrane Database Syst Rev. 2006;CD002096.

    Google Scholar 

Download references

Acknowledgments

The author is indebted to Douglas Arnott (EDMF Translation Bureau, Etyek, Hungary) for correcting the English manuscript for this chapter and chapter “Prognosis.” The secretarial help of Mrs. Jolán Józan (Semmelweis University, Department of Physiology, Budapest, Hungary) is highly appreciated.

Author information

Authors and Affiliations

  1. Department of Gastroenterology, Ferencváros Health Service Non-Profit Ltd, Budapest, Hungary

    György Miklós Buzás

Authors
  1. György Miklós Buzás
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to György Miklós Buzás .

Editor information

Editors and Affiliations

  1. Medical School in Zagreb, University of, Department of Gastroenterology and Hepat, University Hospital “Sestre milosrdnice”, Vinogrdska Str. 29, Zagreb, 10000, Croatia

    Marko Duvnjak

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media LLC

About this chapter

Cite this chapter

Buzás, G.M. (2011). Quality of Life Issues. In: Duvnjak, M. (eds) Dyspepsia in Clinical Practice. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-1730-0_13

Download citation

  • DOI: https://doi.org/10.1007/978-1-4419-1730-0_13

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4419-1729-4

  • Online ISBN: 978-1-4419-1730-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation